A comparison between optimized PLGA and CS-Alg-PLGA microspheres for long-lasting release of glatiramer acetate

[1]  S. Abediankenari,et al.  Treatment of EAE mice with Treg, G-MDSC and IL-2: a new insight into cell therapy for multiple sclerosis. , 2022, Immunotherapy.

[2]  Zheng Zhao,et al.  A hollow chitosan-coated PLGA microsphere to enhance drug delivery and anticancer efficiency , 2022, Journal of Drug Delivery Science and Technology.

[3]  A. Soltani,et al.  In vitro release and cytotoxicity study of encapsulated sulfasalazine within LTSP micellar/liposomal and TSP micellar/niosomal nano-formulations , 2022, Alexandria Engineering Journal.

[4]  Ignacio Fernández,et al.  Synthesis of a Biodegradable PLA: NMR Signal Deconvolution and End-Group Analysis , 2021, Journal of Chemical Education.

[5]  Z. Binkhathlan,et al.  Chitosan-coated poly (lactic-co-glycolide) nanoparticles for dual delivery of doxorubicin and naringin against MCF-7 cells , 2021, Journal of Drug Delivery Science and Technology.

[6]  Ahmad B. Albadarin,et al.  Spectroscopic, density functional theory, cytotoxicity and antioxidant activities of sulfasalazine and naproxen drugs combination , 2021 .

[7]  Ahmed L Alaofi,et al.  Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus , 2021, Pharmaceuticals.

[8]  Ioannis L. Liakos,et al.  Chitosan microparticles as entrapment system for trans-cinnamaldehyde: Synthesis, drug loading, and in vitro cytotoxicity evaluation. , 2020, International journal of biological macromolecules.

[9]  J. Sharifi‐Rad,et al.  Chitosan-decorated nanoparticles for drug delivery , 2020 .

[10]  H. Iovu,et al.  Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine , 2020, Materials & Design.

[11]  Jordan J. Green,et al.  Biomimetic Tolerogenic Artificial Antigen Presenting Cells for Regulatory T Cell Induction. , 2020, Acta biomaterialia.

[12]  A. Azadi,et al.  A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles , 2020, Heliyon.

[13]  A. Rossi,et al.  Lapazine loaded Alginate/Chitosan microparticles: Enhancement of anti-mycobacterium activity , 2019 .

[14]  Y. Açıkel,et al.  Loading of cancer drug resveratrol to pH-Sensitive, smart, alginate-chitosan hydrogels and investigation of controlled release kinetics , 2019, Journal of Drug Delivery Science and Technology.

[15]  W. Britton,et al.  Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis , 2019, Journal of Drug Delivery Science and Technology.

[16]  S. Abediankenari,et al.  Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein. , 2019, Iranian journal of allergy, asthma, and immunology.

[17]  A. Okunlola,et al.  Development of Theophylline Microbeads Using Pregelatinized Breadfruit Starch (Artocarpus altilis) as a Novel Co-polymer for Controlled Release , 2019, Advanced pharmaceutical bulletin.

[18]  Qingdi Zhu,et al.  Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. , 2018, Materials science & engineering. C, Materials for biological applications.

[19]  D. Reich,et al.  Multiple Sclerosis , 2018, The New England journal of medicine.

[20]  N. Ahmed,et al.  Recent applications of PLGA based nanostructures in drug delivery. , 2017, Colloids and surfaces. B, Biointerfaces.

[21]  B. Keselowsky,et al.  An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis. , 2017, Biomaterials.

[22]  M. Shahbazi,et al.  Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis. , 2017, Iranian journal of immunology : IJI.

[23]  S. Miller,et al.  Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  N. Thotakura,et al.  Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen. , 2016, International journal of biological macromolecules.

[25]  J. Pinto,et al.  Influence of PLGA and PLGA-PEG on the dissolution profile of oxaliplatin , 2016 .

[26]  Shweta Sharma,et al.  PLGA-based nanoparticles: A new paradigm in biomedical applications , 2016 .

[27]  M. Gümüşderelioğlu,et al.  Melatonin releasing PLGA micro/nanoparticles and their effect on osteosarcoma cells , 2016, Journal of microencapsulation.

[28]  Patrick J. Short,et al.  Towards programming immune tolerance through geometric manipulation of phosphatidylserine. , 2015, Biomaterials.

[29]  Kisuk Yang,et al.  Biodegradable Nanotopography Combined with Neurotrophic Signals Enhances Contact Guidance and Neuronal Differentiation of Human Neural Stem Cells. , 2015, Macromolecular bioscience.

[30]  Tarek M. Fahmy,et al.  Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF) , 2015, Biomaterials.

[31]  Chengchen Guo,et al.  Investigating Lysine Adsorption on Fumed Silica Nanoparticles , 2014 .

[32]  H. Al‐Lohedan,et al.  Synthesis of Silver Nanoparticles by Green Method Stabilized to Synthetic Human Stomach Fluid , 2014, Molecules.

[33]  J. Barzin,et al.  Incorporation of HSA Microparticles Within the Taxol-Loaded In Situ Forming PLGA Microspheres: Synthesis, Characterization, and Drug Release , 2014 .

[34]  A. Boudier,et al.  PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Yong-yan Bei,et al.  Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole , 2013, International journal of nanomedicine.

[36]  M. Asadian,et al.  Nanolipodendrosome-loaded glatiramer acetate and myogenic differentiation 1 as augmentation therapeutic strategy approaches in muscular dystrophy , 2013, International journal of nanomedicine.

[37]  Richard D Braatz,et al.  Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[38]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[39]  K. Johnson.  Glatiramer acetate for treatment of relapsing–remitting multiple sclerosis , 2012, Expert review of neurotherapeutics.

[40]  M. Mozafari,et al.  Synthesis and characterization of electrospun polyvinyl alcohol nanofibrous scaffolds modified by blending with chitosan for neural tissue engineering , 2012, International journal of nanomedicine.

[41]  E. Topp,et al.  Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[42]  W. Liang,et al.  A one-step modified method to reduce the burst initial release from PLGA microspheres , 2010, Drug delivery.

[43]  A. Compston,et al.  Multiple sclerosis , 2008, The Lancet.

[44]  C. Farina,et al.  Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action , 2005, The Lancet Neurology.

[45]  Michael Sela,et al.  Therapeutic vaccines in autoimmunity , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Arnon,et al.  Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Farina,et al.  Mechanisms of action of glatiramer acetate in multiple sclerosis , 2001, Neurology.

[48]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[49]  N. Peppas.  Analysis of Fickian and non-Fickian drug release from polymers. , 1985, Pharmaceutica acta Helvetiae.

[50]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[51]  J F Goodwin,et al.  Quantification of protein solutions with trinitrobenzenesulfonic acid. , 1970, Clinical chemistry.

[52]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.